<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: UW Scientists, Backed by Gates Foundation, Enter “Put Up or Shut Up” Phase with Portable Diagnostic</title>
	<atom:link href="http://www.xconomy.com/seattle/2009/11/03/uw-scientists-backed-by-gates-foundation-enter-put-up-or-shut-up-phase-with-portable-diagnostic/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/seattle/2009/11/03/uw-scientists-backed-by-gates-foundation-enter-put-up-or-shut-up-phase-with-portable-diagnostic/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 09:14:03 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Melinda Moree</title>
		<link>http://www.xconomy.com/seattle/2009/11/03/uw-scientists-backed-by-gates-foundation-enter-put-up-or-shut-up-phase-with-portable-diagnostic/comment-page-1/#comment-90651</link>
		<dc:creator>Melinda Moree</dc:creator>
		<pubDate>Thu, 05 Nov 2009 06:50:07 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=48551#comment-90651</guid>
		<description>Good story. What would make a better story is companies receiving sufficient funding to push technologies to the point of success or failure much earlier. It is hard to believe that philanthropy is the answer to POC Dx when it seems clear that a U.S. market will develop. Those companies that build POC Dx that can work in the developing world will be way ahead when it comes to minute clinics in the U.S. Are the VCs missing an opportunity?</description>
		<content:encoded><![CDATA[<p>Good story. What would make a better story is companies receiving sufficient funding to push technologies to the point of success or failure much earlier. It is hard to believe that philanthropy is the answer to POC Dx when it seems clear that a U.S. market will develop. Those companies that build POC Dx that can work in the developing world will be way ahead when it comes to minute clinics in the U.S. Are the VCs missing an opportunity?</p>
]]></content:encoded>
	</item>
</channel>
</rss>

